| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0896-6273(00)81109-5 |
| P698 | PubMed publication ID | 10595506 |
| P2093 | author name string | Mesulam MM | |
| P2860 | cites work | Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein | Q22251280 |
| A synaptic model of memory: long-term potentiation in the hippocampus | Q22337276 | ||
| Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors | Q24294213 | ||
| Tau is enriched on dynamic microtubules in the distal region of growing axons | Q24314155 | ||
| Mild cognitive impairment: clinical characterization and outcome | Q28140626 | ||
| Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment | Q29547294 | ||
| Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins | Q29547593 | ||
| Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease | Q29617286 | ||
| Growth-associated protein GAP-43 is expressed selectively in associative regions of the adult human brain | Q33575803 | ||
| Synaptic plasticity in cortical systems | Q33632553 | ||
| Comparative evaluation of synaptophysin-based methods for quantification of synapses | Q34415699 | ||
| Cortical map reorganization enabled by nucleus basalis activity | Q34459799 | ||
| The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort | Q34722192 | ||
| Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid beta/A4 protein precursor | Q35638734 | ||
| Neuronal plasticity and ageing processes in the frame of the 'Red Queen Theory' | Q35857252 | ||
| Nerve growth factor-induced neurite outgrowth in PC12 cells involves the coordinate induction of microtubule assembly and assembly-promoting factors | Q36213686 | ||
| Dendritic Growth in the Aged Human Brain and Failure of Growth in Senile Dementia | Q36537341 | ||
| Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation | Q36548591 | ||
| Alzheimer's disease amyloid precursor protein on the surface of cortical neurons in primary culture co-localizes with adhesion patch components | Q36831631 | ||
| Assessment of normal and mutant human presenilin function in Caenorhabditis elegans | Q37057209 | ||
| Progressive failure of cerebral angiogenesis supporting neural plasticity in aging rats | Q38208749 | ||
| Ovarian steroids and the brain: implications for cognition and aging | Q38464044 | ||
| Cell biology of synaptic plasticity | Q40185965 | ||
| Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease | Q40397850 | ||
| Alzheimer's Disease: Maladaptive Synaptoplasticity Hypothesis | Q40428375 | ||
| Alzheimer's disease: a central role for amyloid | Q40701623 | ||
| Neuropsychological patterns and language deficits in 20 consecutive cases of autopsy-confirmed Alzheimer's disease | Q40841686 | ||
| Dendritic sprouting in Alzheimer's presenile dementia | Q40898751 | ||
| Prospective neuropsychological assessment of nondemented patients with biopsy proven senile plaques | Q40977863 | ||
| Mechanisms of neuronal degeneration in Alzheimer's disease | Q40986730 | ||
| Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis | Q40999741 | ||
| The systems-level organization of cholinergic innervation in the human cerebral cortex and its alterations in Alzheimer's disease. | Q41330670 | ||
| Amyloid, the presenilins and Alzheimer's disease | Q41433661 | ||
| Alzheimer transgenic mouse models come of age. | Q41531400 | ||
| Life and death of neurons in the aging brain | Q41614205 | ||
| Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives | Q41630805 | ||
| Role of apolipoprotein E and estrogen in mossy fiber sprouting in hippocampal slice cultures | Q41676936 | ||
| The role of the amyloid protein precursor (APP) in Alzheimer's disease: does the normal function of APP explain the topography of neurodegeneration? | Q41753871 | ||
| Estrogen-enhanced neurite growth: evidence for a selective induction of Tau and stable microtubules | Q41816898 | ||
| Brain infarction and the clinical expression of Alzheimer disease. The Nun Study | Q42435324 | ||
| Cholinergic depletion reduces plasticity of barrel field cortex | Q42452428 | ||
| The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's Disease | Q42470207 | ||
| Early and rapid de novo synthesis of Alzheimer beta A4-amyloid precursor protein (APP) in activated microglia. | Q42475459 | ||
| Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. III. The basal forebrain compared with other subcortical areas | Q42484200 | ||
| Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele | Q42528671 | ||
| Target-dependent structural changes accompanying long-term synaptic facilitation in Aplysia neurons | Q43585832 | ||
| Amygdala neurons in vitro: neurite growth and effects of estradiol | Q43821688 | ||
| Synthesis and transport of GAP-43 in entorhinal cortex neurons and perforant pathway during lesion-induced sprouting and reactive synaptogenesis | Q43901534 | ||
| The adult rat olfactory system expresses microtubule-associated proteins found in the developing brain | Q44108862 | ||
| Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro | Q45081026 | ||
| Patterns of aberrant sprouting in Alzheimer's disease | Q45166469 | ||
| Re-examination of ex-boxers' brains using immunohistochemistry with antibodies to amyloid ?-protein and tau protein | Q46140201 | ||
| Dendrites, dementia and the Down syndrome. | Q46163302 | ||
| Environmental stimulation of 129/SvJ mice causes increased cell proliferation and neurogenesis in the adult dentate gyrus | Q46271836 | ||
| The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant | Q46323718 | ||
| Tangle-bearing neurons show more extensive dendritic trees than tangle-free neurons in area CA1 of the hippocampus in Alzheimer's disease | Q46503928 | ||
| Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease | Q46611463 | ||
| Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: implications for Alzheimer's disease. | Q46833795 | ||
| Presenilin-1 mutation alters NGF-induced neurite outgrowth, calcium homeostasis, and transcription factor (AP-1) activation in PC12 cells | Q47956308 | ||
| Age and damage induced changes in amyloid protein precursor immunohistochemistry in the rat brain | Q48142042 | ||
| Increased numerical density of synapses in CA3 region of hippocampus and molecular layer of motor cortex after self-stimulation rewarding experience | Q48172479 | ||
| An immunocytochemical and biochemical study of the microtubule-associated protein Tau during post-lesion afferent reorganization in the hippocampus of adult rats | Q48215551 | ||
| Alzheimer neuropathologic alterations in aged cognitively normal subjects | Q48226793 | ||
| The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease | Q48228304 | ||
| Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice | Q48242315 | ||
| Neuroanatomic correlates of visual agnosia in Alzheimer's disease: a clinicopathologic study | Q48298129 | ||
| Effects of PS1 deficiency on membrane protein trafficking in neurons | Q48327056 | ||
| Large-scale sprouting of cortical connections after peripheral injury in adult macaque monkeys | Q48357378 | ||
| Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study. | Q48380653 | ||
| Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment | Q48470952 | ||
| Cortical distribution of neurofibrillary tangles in Alzheimer's disease matches the pattern of neurons that retain their capacity of plastic remodelling in the adult brain | Q48510341 | ||
| Effects of cholinergic depletion on experience-dependent plasticity in the cortex of the rat. | Q48624375 | ||
| Synaptic beta-amyloid precursor proteins increase with learning capacity in rats | Q48631513 | ||
| Secreted form of beta-amyloid precursor protein shifts the frequency dependency for induction of LTD, and enhances LTP in hippocampal slices | Q48659729 | ||
| Cerebrospinal fluid levels of alpha-secretase-cleaved soluble amyloid precursor protein mirror cognition in a Swedish family with Alzheimer disease and a gene mutation | Q48719353 | ||
| Selective alteration of long-term potentiation-induced transcriptional response in hippocampus of aged, memory-impaired rats | Q48728149 | ||
| Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease | Q48820847 | ||
| Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease | Q48865828 | ||
| Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. | Q48963534 | ||
| Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease | Q49103500 | ||
| Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains | Q49112901 | ||
| Head injury and the risk of Alzheimer's disease: a case control study. | Q50955624 | ||
| Selective decline in memory function among healthy elderly. | Q52034186 | ||
| Distribution of the phosphorylated microtubule-associated protein tau in developing cortical neurons. | Q52212514 | ||
| Beta-amyloid from Alzheimer disease brains inhibits sprouting and survival of sympathetic neurons. | Q53297120 | ||
| Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease | Q57306418 | ||
| Neuron loss in APP transgenic mice | Q59060085 | ||
| Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts | Q60010754 | ||
| Synaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic mice | Q60796700 | ||
| Decline in reactive fiber growth in the dentate gyrus of aged rats compared to young adult rats following entorhinal cortex removal. | Q64917388 | ||
| Soluble derivatives of the beta amyloid protein precursor in cerebrospinal fluid: alterations in normal aging and in Alzheimer's disease | Q67298810 | ||
| Perforated synapses on double-headed dendritic spines: a possible structural substrate of synaptic plasticity | Q69597370 | ||
| Concentrations of amyloid-beta protein in cerebrospinal fluid increase with age in patients free from neurodegenerative disease | Q72184863 | ||
| Mab22C11 antibody to amyloid precursor protein recognizes a protein associated with specific astroglial cells of the rat central nervous system characterized by their capacity to support axonal outgrowth | Q73009982 | ||
| A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging | Q73434963 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| neuroplasticity | Q849491 | ||
| P304 | page(s) | 521-529 | |
| P577 | publication date | 1999-11-01 | |
| P1433 | published in | Neuron | Q3338676 |
| P1476 | title | Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles | |
| P478 | volume | 24 |
| Q92925600 | A Computerized Continuous-Recognition Task for Measurement of Episodic Memory |
| Q48943001 | A case for a non-transgenic animal model of Alzheimer's disease |
| Q36628146 | A network dysfunction perspective on neurodegenerative diseases |
| Q37852103 | A new chapter in the field of memory: adult hippocampal neurogenesis. |
| Q52892366 | A potential therapeutic effect of Saikosaponin C as a novel dual-target anti-Alzheimer agent. |
| Q33985604 | A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging |
| Q28265282 | APOE genotype effects on Alzheimer's disease onset and epidemiology |
| Q44281893 | Aberrant activation of focal adhesion proteins mediates fibrillar amyloid beta-induced neuronal dystrophy. |
| Q43751849 | Aberrant induction of Par-4 is involved in apoptosis of hippocampal neurons in presenilin-1 M146V mutant knock-in mice |
| Q34984088 | Absent event-related potential (ERP) word repetition effects in mild Alzheimer's disease |
| Q48712299 | Accelerated longitudinal gray/white matter contrast decline in aging in lightly myelinated cortical regions |
| Q34570846 | Accumulation of intraneuronal β-amyloid 42 peptides is associated with early changes in microtubule-associated protein 2 in neurites and synapses |
| Q48591710 | Active endocytosis and microtubule remodeling restore compressed pyramidal neuron morphology in rat cerebral cortex |
| Q37108156 | Advances on the understanding of the origins of synaptic pathology in AD. |
| Q46513652 | Age-related alterations of oxidative stress markers in the mouse hippocampal CA1 sector |
| Q46637697 | Age-related changes of NGF, BDNF, parvalbumin and neuronal nitric oxide synthase immunoreactivity in the mouse hippocampal CA1 sector |
| Q46390661 | Age-related changes of calcineurin and Akt1/protein kinase Balpha (Akt1/PKBalpha) immunoreactivity in the mouse hippocampal CA1 sector: an immunohistochemical study |
| Q34114011 | Altered histone acetylation is associated with age-dependent memory impairment in mice. |
| Q33805339 | Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. |
| Q30535426 | Alzheimer brain-derived amyloid β-protein impairs synaptic remodeling and memory consolidation |
| Q34142269 | Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization |
| Q36943464 | Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals |
| Q57074482 | Alzheimer's disease, estrogens, and clinical trials: a case study in drug development for complex disorders |
| Q37653352 | Alzheimer's disease: The influence of age on clinical heterogeneity through the human brain connectome |
| Q37636545 | Alzheimer's disease: synaptic dysfunction and Abeta |
| Q92176298 | Amygdaloid complex anatomopathological findings in animal models of status epilepticus |
| Q27009411 | Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease |
| Q37698159 | Amyloid deposition is linked to aberrant entorhinal activity among cognitively normal older adults |
| Q49256155 | Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons |
| Q42568400 | Amyloid-beta1-42 reduces neuronal excitability in mouse dentate gyrus |
| Q37603879 | Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease. |
| Q34814145 | Amyloid-β as a Modulator of Synaptic Plasticity |
| Q37345237 | An evaluation of recollection and familiarity in Alzheimer's disease and mild cognitive impairment using receiver operating characteristics. |
| Q30341746 | ApoE-dependent plasticity in Alzheimer's disease. |
| Q39135327 | Approach to atypical Alzheimer's disease and case studies of the major subtypes. |
| Q34137676 | Assessment of spatial memory in mice |
| Q28390187 | Astrocyte heterogeneity in the brain: from development to disease |
| Q92525356 | Aβ-induced vulnerability propagates via the brain's default mode network |
| Q37061555 | BDNF and the diseased nervous system: a delicate balance between adaptive and pathological processes of gene regulation. |
| Q38654081 | BDNF genotype is associated with hippocampal volume in mild traumatic brain injury. |
| Q90592712 | Basal forebrain volume reliably predicts the cortical spread of Alzheimer's degeneration |
| Q37592824 | Biomarker modeling of Alzheimer's disease |
| Q36551980 | Brain aerobic glycolysis functions and Alzheimer's disease |
| Q22252362 | Brain cholinesterases: II. The molecular and cellular basis of Alzheimer's disease |
| Q30984127 | Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. |
| Q34445162 | Brain-derived neurotrophic factor exerts neuroprotective actions against amyloid β-induced apoptosis in neuroblastoma cells |
| Q34017880 | Brain-derived neurotrophic factor in neurodegenerative diseases |
| Q34065279 | Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease |
| Q33857179 | CREB couples neurotrophin signals to survival messages |
| Q33689474 | CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease |
| Q36795245 | Cardiovascular risk in cognitively preserved elderlies is associated with glucose hypometabolism in the posterior cingulate cortex and precuneus regardless of brain atrophy and apolipoprotein gene variations |
| Q36722181 | Cascading network failure across the Alzheimer's disease spectrum |
| Q104459210 | Cellular correlates of cortical thinning throughout the lifespan |
| Q43668255 | Cerebrovascular melatonin MT1-receptor alterations in patients with Alzheimer's disease |
| Q48495532 | Characterization of neuronal dystrophy induced by fibrillar amyloid beta: implications for Alzheimer's disease |
| Q34245359 | Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer's disease |
| Q35687034 | Chronic stress and Alzheimer's disease-like pathogenesis in a rat model: prevention by nicotine |
| Q35918813 | Clinically concordant variations of Alzheimer pathology in aphasic versus amnestic dementia |
| Q30800136 | Cognitive decline and brain pathology in aging--need for a dimensional, lifespan and systems vulnerability view |
| Q38059910 | Cognitive decline in older adults with a history of traumatic brain injury |
| Q42588280 | Cognitive event-related potentials: biomarkers of synaptic dysfunction across the stages of Alzheimer's disease |
| Q28071285 | Cognitive interventions in Alzheimer's and Parkinson's diseases: emerging mechanisms and role of imaging |
| Q35907510 | Cognitive reserve, cortical plasticity and resistance to Alzheimer's disease |
| Q34242083 | Decreased Default Mode Network connectivity correlates with age-associated structural and cognitive changes |
| Q46644344 | Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function |
| Q37362101 | Degenerating synaptic boutons in prion disease: microglia activation without synaptic stripping |
| Q35973450 | Dendritic BC200 RNA in aging and in Alzheimer's disease |
| Q47268354 | Differential expression of LMO4 protein in Alzheimer's disease |
| Q37248729 | Distinct medial temporal contributions to different forms of recognition in amnestic mild cognitive impairment and Alzheimer's disease. |
| Q39338486 | Do Circadian Rhythms Draw the Patterns of Sustained Mental Vigor and Ailment? |
| Q37456054 | Does Alzheimer's disease begin in the brainstem? |
| Q36003859 | Does beta-amyloid plaque formation cause structural injury to neuronal processes? |
| Q48773448 | Education and occupation provide reserve in both ApoE ε4 carrier and noncarrier patients with probable Alzheimer's disease. |
| Q44314293 | Effect of melatonin on changes in locomotor activity rhythm of Syrian hamsters injected with beta amyloid peptide 25-35 in the suprachiasmatic nuclei |
| Q36462403 | Effects of Beta-Amyloid on Resting State Functional Connectivity Within and Between Networks Reflect Known Patterns of Regional Vulnerability |
| Q36321742 | Effects of cancer therapy on hippocampus-related function |
| Q35111592 | Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for Difficult-to-Treat depression |
| Q35236446 | Enhancing synaptic plasticity and cellular resilience to develop novel, improved treatments for mood disorders. |
| Q36003831 | Environmentally induced long-term structural changes: cues for functional orientation and vulnerabilities |
| Q28748164 | Epigenetics and psychoneuroimmunology: Mechanisms and models |
| Q37569847 | Exercise and bipolar disorder: a review of neurobiological mediators. |
| Q35792038 | FDG- and amyloid-PET in Alzheimer's disease: is the whole greater than the sum of the parts? |
| Q50462256 | Feeling, learning from and being aware of inner states: interoceptive dimensions in neurodegeneration and stroke. |
| Q36744065 | From amnesia to dementia: ERP studies of memory and language |
| Q38419997 | Functional Changes in the Language Network in Response to Increased Amyloid β Deposition in Cognitively Intact Older Adults |
| Q33967680 | Functional network disruption in the degenerative dementias |
| Q35753450 | Future directions in the treatment of Alzheimer's disease |
| Q35850597 | GAP-43 gene expression regulates information storage. |
| Q30530712 | Galanin transgenic mice display cognitive and neurochemical deficits characteristic of Alzheimer's disease. |
| Q74244462 | Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits |
| Q34509807 | Genetically engineered models relevant to neurodegenerative disorders: their value for understanding disease mechanisms and designing/testing experimental therapeutics |
| Q34708236 | Genetically engineered mouse models of neurodegenerative diseases |
| Q38227862 | Glia and zinc in ageing and Alzheimer's disease: a mechanism for cognitive decline? |
| Q30489836 | High consistency of regional cortical thinning in aging across multiple samples |
| Q34716110 | Hippocampal N-acetylaspartate concentration and response to riluzole in generalized anxiety disorder |
| Q31123604 | Hippocampal gene expression meta-analysis identifies aging and age-associated spatial learning impairment (ASLI) genes and pathways |
| Q36725261 | Hippocampal hypometabolism predicts cognitive decline from normal aging |
| Q36054541 | Hippocampal plasticity during the progression of Alzheimer's disease |
| Q61800973 | Impaired Spatial Reorientation in the 3xTg-AD Mouse Model of Alzheimer's Disease |
| Q35105340 | Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD |
| Q28200916 | Increased melatonin 1a-receptor immunoreactivity in the hippocampus of Alzheimer's disease patients |
| Q58552626 | Increased posterior default mode network activity and structural connectivity in young adult APOE-ε4 carriers: a multimodal imaging investigation |
| Q35246412 | Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease |
| Q36294110 | Investigating Wnt signaling: a chemogenomic safari |
| Q35708618 | Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention |
| Q35510426 | Lifespan brain activity, β-amyloid, and Alzheimer's disease |
| Q30835713 | Locus coeruleus cellular and molecular pathology during the progression of Alzheimer's disease |
| Q30988163 | Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease |
| Q35105385 | Medial temporal lobe function and structure in mild cognitive impairment |
| Q46813446 | Membrane lipid rafts and neurobiology: age-related changes in membrane lipids and loss of neuronal function |
| Q64767457 | Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases |
| Q35483725 | Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve |
| Q38832895 | MicroRNA-34c Downregulation Ameliorates Amyloid-β-Induced Synaptic Failure and Memory Deficits by Targeting VAMP2. |
| Q37210364 | Mild cognitive impairment in adult: A neuropsychological review |
| Q38890523 | Mitochondrial Regulatory Pathways in the Pathogenesis of Alzheimer's Disease |
| Q38836004 | Molecular and cellular pathophysiology of preclinical Alzheimer's disease |
| Q59854882 | Molecular properties underlying regional vulnerability to Alzheimer's disease pathology |
| Q35020322 | Morphometric and histologic substrates of cingulate integrity in elders with exceptional memory capacity |
| Q34156343 | Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice. |
| Q47617559 | Neuron-Targeted Caveolin-1 Improves Molecular Signaling, Plasticity, and Behavior Dependent on the Hippocampus in Adult and Aged Mice |
| Q46043096 | Neuron-Targeted Caveolin-1 Promotes Ultrastructural and Functional Hippocampal Synaptic Plasticity |
| Q52541461 | Neuronal plasticity and survival in mood disorders. |
| Q34111006 | Neuroplasticity and cellular resilience in mood disorders |
| Q34976296 | Neuroplasticity in Alzheimer's disease |
| Q34094753 | Neurotoxicity of cancer chemotherapy |
| Q47589539 | Oligodendrocytes are a novel source of amyloid peptide generation |
| Q34192388 | Overview and perspective on the therapy of Alzheimer's disease from a preclinical viewpoint |
| Q46148617 | Parallel Compensatory and Pathological Events Associated with Tau Pathology in Middle Aged Individuals with Down Syndrome |
| Q48496690 | Phosphorylation of actin-depolymerizing factor/cofilin by LIM-kinase mediates amyloid beta-induced degeneration: a potential mechanism of neuronal dystrophy in Alzheimer's disease. |
| Q37184490 | Polymorphism of brain derived neurotrophic factor influences β amyloid load in cognitively intact apolipoprotein E ε4 carriers |
| Q22252516 | Potential benefits of mindfulness-based interventions in mild cognitive impairment and Alzheimer's disease: An interdisciplinary perspective |
| Q37698055 | Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging |
| Q36484091 | Precortical Phase of Alzheimer's Disease (AD)-Related Tau Cytoskeletal Pathology |
| Q34460661 | Presenilin-1 binds cytoplasmic epithelial cadherin, inhibits cadherin/p120 association, and regulates stability and function of the cadherin/catenin adhesion complex |
| Q49078080 | Presenilin-1 mutations reduce cytoskeletal association, deregulate neurite growth, and potentiate neuronal dystrophy and tau phosphorylation. |
| Q37298543 | Preserved frontal memorial processing for pictures in patients with mild cognitive impairment. |
| Q37696939 | Progression of tau pathology within cholinergic nucleus basalis neurons in chronic traumatic encephalopathy: A chronic effects of neurotrauma consortium study |
| Q44028725 | Progressive decrease of amyloid precursor protein carboxy terminal fragments (APP-CTFs), associated with tau pathology stages, in Alzheimer's disease. |
| Q52324954 | RNA-Dependent Intergenerational Inheritance of Enhanced Synaptic Plasticity after Environmental Enrichment. |
| Q40477472 | Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease. |
| Q46737371 | Reduced neuronal expression of synaptic transmission modulator HNK-1/neural cell adhesion molecule as a potential consequence of amyloid beta-mediated oxidative stress: a proteomic approach |
| Q37199042 | Reduced pCREB in Alzheimer's disease prefrontal cortex is reflected in peripheral blood mononuclear cells |
| Q30535298 | Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's disease |
| Q58567886 | Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer's Dementia |
| Q48232761 | Reversible paired helical filament-like phosphorylation of tau is an adaptive process associated with neuronal plasticity in hibernating animals. |
| Q47110501 | Rho GTPases as therapeutic targets in Alzheimer's disease |
| Q38486605 | Right hemisphere recruitment during language processing in frontotemporal lobar degeneration and Alzheimer's disease |
| Q37972068 | Road to Alzheimer's disease: the pathomechanism underlying |
| Q28202553 | Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory |
| Q33707724 | Selective disruption of the cerebral neocortex in Alzheimer's disease |
| Q36226953 | Single photon emission computed tomography perfusion differences in mild cognitive impairment |
| Q53245545 | Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. |
| Q33925396 | Spatial memory is enhanced in long-living Ames dwarf mice and maintained following kainic acid induced neurodegeneration |
| Q33717296 | Spatial memory performances of aged rats in the water maze predict levels of hippocampal neurogenesis |
| Q24535750 | Specific inhibition of CBP/beta-catenin interaction rescues defects in neuronal differentiation caused by a presenilin-1 mutation |
| Q37705451 | Stress, Inflammation, and Cellular Vulnerability during Early Stages of Affective Disorders: Biomarker Strategies and Opportunities for Prevention and Intervention |
| Q38658765 | Stress, depression, resilience and ageing: A role for the LPA-LPA1 pathway. |
| Q36688731 | Subtle changes in the ageing human brain |
| Q47574168 | Synaptic pathology in prefrontal cortex is present only with severe dementia in Alzheimer disease |
| Q24675772 | Synaptic plasticity in animal models of early Alzheimer's disease |
| Q26859909 | Targeting Hsp90/Hsp70-based protein quality control for treatment of adult onset neurodegenerative diseases |
| Q34127542 | Targeting S100B in Cerebral Ischemia and in Alzheimer's Disease |
| Q40421137 | Tau 6D and 6P isoforms inhibit polymerization of full-length tau in vitro |
| Q91011085 | Tau PET imaging in neurodegenerative tauopathies-still a challenge |
| Q35019484 | Tau aggregation in the hippocampal formation: an ageing or a pathological process? |
| Q47987344 | Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum |
| Q35020774 | Temporal profiles of synaptic plasticity-related signals in adult mouse hippocampus with methotrexate treatment. |
| Q60912439 | The 12-Word Philadelphia Verbal Learning Test Performances in Older Adults: Brain MRI and Cerebrospinal Fluid Correlates and Regression-Based Normative Data |
| Q26863130 | The CARE pathway model for dementia: psychosocial and rehabilitative strategies for care in young-onset dementias |
| Q35860467 | The Familial British Dementia Mutation Promotes Formation of Neurotoxic Cystine Cross-linked Amyloid Bri (ABri) Oligomers |
| Q41101016 | The GAB2 and BDNF polymorphisms and the risk for late-onset Alzheimer's disease in an elderly Brazilian sample |
| Q92257585 | The Potential Role of MicroRNA-124 in Cerebral Ischemia Injury |
| Q46915612 | The Roots of Alzheimer's Disease: Are High-Expanding Cortical Areas Preferentially Targeted?†. |
| Q34236134 | The cellular neurobiology of depression |
| Q35598381 | The cholinergic innervation of the human cerebral cortex |
| Q26822504 | The dynamic role of beta-catenin in synaptic plasticity |
| Q33658827 | The native copper- and zinc-binding protein metallothionein blocks copper-mediated Abeta aggregation and toxicity in rat cortical neurons. |
| Q34562614 | The underlying neurobiology of bipolar disorder |
| Q42435326 | Therapeutic potential of CERE-110 (AAV2-NGF): targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons |
| Q29620245 | Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers |
| Q43943091 | Transgenic mice expressing the human presenilin 1 gene demonstrate enhanced hippocampal reorganization following entorhinal cortex lesions |
| Q29547778 | Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction |
| Q35032088 | Ubiquitin and synaptic dysfunction: ataxic mice highlight new common themes in neurological disease |
| Q31840196 | Use-dependent effects of amyloidogenic fragments of (beta)-amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo. |
| Q35170198 | What can rodent models tell us about cognitive decline in Alzheimer's disease? |
| Q30850844 | What have novel imaging techniques revealed about metabolism in the aging brain? |
| Q35129501 | What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus |
| Q74265101 | What is the function of receptor and membrane endocytosis at the postsynaptic neuron? |
| Q41440719 | White Matter Hyperintensity Load Modulates Brain Morphometry and Brain Connectivity in Healthy Adults: A Neuroplastic Mechanism? |
| Q35422390 | microRNA-34c is a novel target to treat dementias |
Search more.